EP133 – Current status of robotic thyroid surgery in Europe – Experience of 600 procedures at the American Hospital of Paris

     

    Aidan, Patrick1; Bechara, Maroun1; Monpeyssen, Herve2
    1 Department of Otolaryngology – Head and Neck Surgery, American Hospital of Paris, Neuilly sur seine, France
    2 Division of Thyroidology, Department of radiology, American Hospital of Paris, Neuilly sur seine, France

     

    Introduction: Thyroid surgery is in a state of evolution from traditional open approaches to novel robotic techniques. The transaxillary robotic surgery (TARS) of thyroid is effective in the management of thyroid cancer. Complications are no higher than open or endoscopic techniques. TARS also avoids the anterior neck scar. This communication presents what the authors believe to be the largest cohort of patients reported in Europe undergoing robotic thyroid surgery with the aim of defining the indications for this procedure.

    Methods:  Six hundred patients underwent TARS of thyroid were enrolled in this study between march 2010 and February 2017. All patients were operated by one surgeon at one clinical centre. Data reviewed included patient characteristics, pathological characteristics, extend of surgery and post operative complications. The mean follow up was 34.29 month.

    Materials: 600 patients underwent 603 procedures; the average age of the patients was 43 years and male to female ratio of 1:22. Surgeries were 174 lobectomies, 22 subtotal thyroidectomies, 407 total thyroidectomies.

    Conclusion: TARS of thyroid has been shown to be efficient in the management of thyroid cancer. This technique is also suitable for benign diseases, including goiters and Grave’s disease. Careful patient selection, in terms of patient characteristics and anatomical aspects of the lesion, is fundamental to achieve safe and successful surgeries. The excellent cosmetic results of this procedure make it ideal for patients who have aesthetic concerns and abnormal wound healing.

 

Leave a Reply

  • Upcoming Events

     

    World Congress on Thyroid Cancer 3.5
    Rome, Italy | 2019

    World Congress on Thyroid Cancer 4.0
    July 29 – August 1, 2021
    Boston, Massachusetts